Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

A DNA pool of FLT3-ITD positive DNA samples can be used efficiently for analytical evaluation of NGS-based FLT3-ITD quantitation - Testing several different ITD sequences and rates, simultaneously.

Mezei ZA, Tornai D, Földesi R, Madar L, Sümegi A, Papp M, Antal-Szalmás P.

J Biotechnol. 2019 Sep 10;303:25-29. doi: 10.1016/j.jbiotec.2019.06.305. Epub 2019 Jul 11.

PMID:
31302157
2.

Comparative effectiveness of teriflunomide and dimethyl fumarate: A nationwide cohort study.

Buron MD, Chalmer TA, Sellebjerg F, Frederiksen J, Góra MK, Illes Z, Kant M, Mezei Z, Petersen T, Rasmussen PV, Roshanisefat H, Hassanpour-Kalam-Roudy H, Sejbæk T, Tsakiri A, Weglewski A, Sorensen PS, Magyari M.

Neurology. 2019 Apr 16;92(16):e1811-e1820. doi: 10.1212/WNL.0000000000007314. Epub 2019 Mar 15.

PMID:
30877188
3.

Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark.

Papp V, Illes Z, Magyari M, Koch-Henriksen N, Kant M, Pfleger CC, Roemer SF, Jensen MB, Petersen AE, Nielsen HH, Rosendahl L, Mezei Z, Christensen T, Svendsen K, Hyldgaard Jensen PE, Lydolph MC, Heegaard N, Frederiksen JL, Sellebjerg F, Stenager E, Petersen T.

Neurology. 2018 Dec 11;91(24):e2265-e2275. doi: 10.1212/WNL.0000000000006645. Epub 2018 Nov 9.

4.

[Pernicious anemia in a thalassemic patient - difficulties of the diagnosis].

Kurdi B, Mezei ZA, Kellner Á, Egyed M.

Orv Hetil. 2018 Aug;159(33):1368-1371. doi: 10.1556/650.2018.31097. Hungarian.

PMID:
30099903
5.

Low factor XIII levels after intravenous thrombolysis predict short-term mortality in ischemic stroke patients.

Székely EG, Czuriga-Kovács KR, Bereczky Z, Katona É, Mezei ZA, Nagy A, Tóth NK, Berényi E, Muszbek L, Csiba L, Bagoly Z.

Sci Rep. 2018 May 16;8(1):7662. doi: 10.1038/s41598-018-26025-z.

6.

Effect of factor XIII levels and polymorphisms on the risk of myocardial infarction in young patients.

Balogh L, Katona É, Mezei ZA, Kállai J, Gindele R, Édes I, Muszbek L, Papp Z, Bereczky Z.

Mol Cell Biochem. 2018 Nov;448(1-2):199-209. doi: 10.1007/s11010-018-3326-8. Epub 2018 Feb 26.

PMID:
29484525
7.

Vitamin D deficiency causes inward hypertrophic remodeling and alters vascular reactivity of rat cerebral arterioles.

Pál É, Hadjadj L, Fontányi Z, Monori-Kiss A, Mezei Z, Lippai N, Magyar A, Heinzlmann A, Karvaly G, Monos E, Nádasy G, Benyó Z, Várbíró S.

PLoS One. 2018 Feb 6;13(2):e0192480. doi: 10.1371/journal.pone.0192480. eCollection 2018.

8.

Oxidative Stress-Related Parthanatos of Circulating Mononuclear Leukocytes in Heart Failure.

Bárány T, Simon A, Szabó G, Benkő R, Mezei Z, Molnár L, Becker D, Merkely B, Zima E, Horváth EM.

Oxid Med Cell Longev. 2017;2017:1249614. doi: 10.1155/2017/1249614. Epub 2017 Nov 9.

9.

The Murine Factor H-Related Protein FHR-B Promotes Complement Activation.

Cserhalmi M, Csincsi ÁI, Mezei Z, Kopp A, Hebecker M, Uzonyi B, Józsi M.

Front Immunol. 2017 Sep 19;8:1145. doi: 10.3389/fimmu.2017.01145. eCollection 2017.

10.

Factor XIII levels and factor XIII B subunit polymorphisms in patients with venous thromboembolism.

Mezei ZA, Katona É, Kállai J, Bereczky Z, Somodi L, Molnár É, Kovács B, Miklós T, Ajzner É, Muszbek L.

Thromb Res. 2017 Oct;158:93-97. doi: 10.1016/j.thromres.2017.08.018. Epub 2017 Aug 26.

PMID:
28865246
11.

Browning deficiency and low mobilization of fatty acids in gonadal white adipose tissue leads to decreased cold-tolerance of transglutaminase 2 knock-out mice.

Mádi A, Cuaranta-Monroy I, Lénárt K, Pap A, Mezei ZA, Kristóf E, Oláh A, Vámosi G, Bacsó Z, Bai P, Fésüs L.

Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Dec;1862(12):1575-1586. doi: 10.1016/j.bbalip.2017.07.014. Epub 2017 Aug 1.

PMID:
28774822
12.

Effects of kisspeptin on diabetic rat platelets.

Mezei Z, Váczi S, Török V, Stumpf C, Ónody R, Földesi I, Szabó G.

Can J Physiol Pharmacol. 2017 Nov;95(11):1319-1326. doi: 10.1139/cjpp-2017-0036. Epub 2017 Jul 26.

PMID:
28746808
13.

Regulation of plasma factor XIII levels in healthy individuals; a major impact by subunit B intron K c.1952+144 C>G polymorphism.

Mezei ZA, Katona É, Kállai J, Bereczky Z, Molnár É, Kovács B, Ajzner É, Bagoly Z, Miklós T, Muszbek L.

Thromb Res. 2016 Dec;148:101-106. doi: 10.1016/j.thromres.2016.10.025. Epub 2016 Oct 27.

PMID:
27821352
14.

The effect of kisspeptin on the regulation of vascular tone.

Mezei Z, Zamani-Forooshani O, Csabafi K, Szikszai B, Papp E, Ónodi Á, Török D, Leprán Á, Telegdy G, Szabó G.

Can J Physiol Pharmacol. 2015 Sep;93(9):787-91. doi: 10.1139/cjpp-2015-0013. Epub 2015 Apr 28.

PMID:
26242914
15.

Factor XIII B subunit polymorphisms and the risk of coronary artery disease.

Mezei ZA, Bereczky Z, Katona É, Gindele R, Balogh E, Fiatal S, Balogh L, Czuriga I, Ádány R, Édes I, Muszbek L.

Int J Mol Sci. 2015 Jan 6;16(1):1143-59. doi: 10.3390/ijms16011143. Erratum in: Int J Mol Sci. 2015;16(4):7375-6.

16.

Factor XIII-A subunit Val34Leu polymorphism in fatal atherothrombotic ischemic stroke.

Shemirani AH, Antalfi B, Pongrácz E, Mezei ZA, Bereczky Z, Csiki Z.

Blood Coagul Fibrinolysis. 2014 Jun;25(4):364-8. doi: 10.1097/MBC.0000000000000055.

PMID:
24686102
17.

Cerebrovascular hemodynamic changes in multiple sclerosis patients during head-up tilt table test: effect of high-dose intravenous steroid treatment.

Mezei Z, Olah L, Kardos L, Kovacs RK, Csiba L, Csepany T.

J Neurol. 2013 Sep;260(9):2335-42. doi: 10.1007/s00415-013-6977-0. Epub 2013 Jun 12.

PMID:
23760630
18.

Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing-remitting multiple sclerosis?

Mezei Z, Bereczki D, Racz L, Csiba L, Csepany T.

Neuropsychiatr Dis Treat. 2012;8:465-73. doi: 10.2147/NDT.S36771. Epub 2012 Oct 23.

19.

Factor XIII-A subunit Val34Leu polymorphism in fatal hemorrhagic stroke.

Antalfi B, Pongrácz E, Csiki Z, Mezei ZA, Shemirani AH.

Int J Lab Hematol. 2013 Feb;35(1):88-91. doi: 10.1111/j.1751-553X.2012.01465.x. Epub 2012 Aug 22.

PMID:
22909010
20.

Thrombomodulin-dependent effect of factor V Leiden mutation on the cross-linking of α2-plasmin inhibitor to fibrin and its consequences on fibrinolysis.

Koncz Z, Bagoly Z, Haramura G, Mezei ZA, Muszbek L.

Thromb Res. 2012 Sep;130(3):528-34. doi: 10.1016/j.thromres.2012.05.019. Epub 2012 Jun 15.

PMID:
22704462
21.

Thrombomodulin-dependent effect of factor VLeiden mutation on factor XIII activation.

Koncz Z, Bagoly Z, Haramura G, Mezei ZA, Muszbek L.

Thromb Res. 2012 Apr;129(4):508-13. doi: 10.1016/j.thromres.2011.06.030. Epub 2011 Jul 20.

PMID:
21774968
22.

Effects of 3-aminopyridine-induced seizures on platelet eicosanoid synthesis.

Csányi G, Kis B, Gecse A, Telegdy G, Szupera Z, Vécsei L, Szente M, Leprán I, Mezei Z.

Pharmacol Rep. 2008 May-Jun;60(3):345-52.

23.

Lack of endothelium-derived hyperpolarizing factor (EDHF) up-regulation in endothelial dysfunction in aorta in diabetic rats.

Csanyi G, Lepran I, Flesch T, Telegdy G, Szabo G, Mezei Z.

Pharmacol Rep. 2007 Jul-Aug;59(4):447-55.

24.

[Long-term application of the multiple sclerosis functional composite test in Debrecen, Hungary].

Mezei Z, Bereczki D, Csiba L, Csépány T.

Ideggyogy Sz. 2006 Nov 20;59(11-12):442-7. Hungarian.

PMID:
17203882
25.

[Application of the Multiple Sclerosis Functional Composite in Debrecen].

Mezei Z, Bereczki D, Csiba L, Csépány T.

Ideggyogy Sz. 2005 Mar 20;58(3-4):113-8. Hungarian.

PMID:
15887414
26.

In vivo effects of isatin on rat platelet eicosanoids.

Pataki I, Mezei Z, Adamik A, Glover V, Gecse A, Telegdy G.

Platelets. 2005 Feb;16(1):39-43.

PMID:
15763895
27.

Prostanoid synthesis in the cerebral blood vessels of asphyxiated piglets.

Kis B, Mezei Z, Forgács P, Gecse A, Telegdy G, Bari F.

Acta Physiol Hung. 2001;88(2):87-100.

PMID:
11999809
28.

Platelet arachidonate cascade of migraineurs in the interictal phase.

Mezei Z, Kis B, Gecse A, Tajti J, Boda B, Telegdy G, Vécsei L.

Platelets. 2000 Jun;11(4):222-5.

PMID:
10938901
29.

The effects of valproate on the arachidonic acid metabolism of rat brain microvessels and of platelets.

Szupera Z, Mezei Z, Kis B, Gecse A, Vécsei L, Telegdy G.

Eur J Pharmacol. 2000 Jan 10;387(2):205-10.

PMID:
10650161
30.

Effects of pituitary adenylate cyclase-activating polypeptide on the cyclooxygenase pathway of rat platelets and on platelet aggregation.

Kis B, Mezei Z, Dancsó G, Pataricza J, Gecse A, Papp JG, Telegdy G.

Prostaglandins Other Lipid Mediat. 1999 Oct;58(2-4):103-12.

PMID:
10560613
31.

Pituitary adenylate cyclase-activating polypeptide inhibits the cyclooxygenase pathway of rat cerebral microvessels.

Kis B, Gáspár T, Mezei Z, Gecse A, Telegdy G.

Acta Physiol Scand. 1999 Sep;167(1):43-7.

PMID:
10519976
32.

Effects of inflammatory neuropeptides on the arachidonate cascade of platelets.

Gecse A, Kis B, Mezei Z, Telegdy G.

Int Arch Allergy Immunol. 1999 Feb-Apr;118(2-4):166-70.

PMID:
10224368
33.

Vasoactive substances produced by cultured rat brain endothelial cells.

Kis B, Szabó CA, Pataricza J, Krizbai IA, Mezei Z, Gecse A, Telegdy G, Papp JG, Deli MA.

Eur J Pharmacol. 1999 Feb 26;368(1):35-42.

PMID:
10096767
34.

Valproate treatment and platelet function: the role of arachidonate metabolites.

Kis B, Szupera Z, Mezei Z, Gecse A, Telegdy G, Vécsei L.

Epilepsia. 1999 Mar;40(3):307-10.

35.

Platelet eicosanoids and the effect of captopril in blood pressure regulation.

Mezei Z, Kis B, Gecse A, Telegdy G, Abrahám G, Sonkodi S.

Eur J Pharmacol. 1997 Dec 4;340(1):67-73.

PMID:
9527508
36.

The effect of substance P on the arachidonate cascade of rat platelets.

Kis B, Mezei Z, Gecse A, Telegdy G.

Acta Physiol Hung. 1997-1998;85(2):89-97.

PMID:
9706302
37.

The effect of bradykinin and substance P on the arachidonate cascade of platelets.

Gecse A, Kis B, Mezei Z, Telegdy G.

Immunopharmacology. 1996 Jun;33(1-3):167-70.

PMID:
8856141
38.

C4B*Q0 allotype as risk factor for myocardial infarction.

Kramer J, Rajczy K, Hegyi L, Fülöp T, Mohácsi A, Mezei Z, Keltai M, Blaskó G, Ferenczy E, Anh-Tuan N, et al.

BMJ. 1994 Jul 30;309(6950):313-4. No abstract available.

39.

The effect of angiotensin I and III on the arachidonate cascade of brain microvessels.

Zádori J, Gecse A, Mezei Z, Telegdy G.

Acta Physiol Hung. 1990;75 Suppl:303-4. No abstract available.

PMID:
2115237
40.

The action of angiotensin II on the arachidonate cascade of brain microvessels.

Gecse A, Mezei Z, Telegdy G.

Acta Physiol Hung. 1990;75 Suppl:129-30. No abstract available.

PMID:
2115225
41.

The effect of bradykinin and its fragments on the arachidonate cascade of brain microvessels.

Gecse A, Mezei Z, Telegdy G.

Adv Exp Med Biol. 1989;247A:249-54.

PMID:
2603791
42.

The effects of somatostatin on the arachidonate cascade of platelets.

Mezei Z, Gecse A, Telegdy G.

Prostaglandins. 1988 Sep;36(3):399-408.

PMID:
2907167
43.

Arachidonate cascade in mesenteric blood vessels and platelets of spontaneously hypertensive rats.

Gecse A, Sonkondi S, Mezei Z, Telegdy G.

Agents Actions Suppl. 1987;22:43-8.

PMID:
3124556
44.

The action of peptides and proteases on the arachidonate cascade of human and rat platelets.

Gecse A, Mezei Z, Telegdy G.

Adv Exp Med Biol. 1986;198 Pt B:121-8.

PMID:
2880482
45.

Histamine-stimulated prostaglandin synthesis in rat brain microvessels.

Dux E, Joó F, Gecse A, Mezei Z, Dux L, Hideg J, Telegdy G.

Agents Actions. 1982 Apr;12(1-2):146-8.

PMID:
6805263
46.

Prostacyclin and prostaglandin synthesis in isolated brain capillaries.

Gecse A, Ottlecz A, Mezei Z, Telegdy G, Joó F, Dux E, Karnushina I.

Prostaglandins. 1982 Mar;23(3):287-97.

PMID:
6808590
47.

Histamine in brain capillaries.

Joó F, Dux E, Karnushina IL, Halász N, Gecse A, Ottlecz A, Mezei Z.

Agents Actions. 1981 Apr;11(1-2):129-34.

PMID:
7018196
48.

Prostacyclin and prostaglandin synthesis in rat brain microvessels: characteristic changes in hypoxaemia.

Dux E, Joó F, Hideg J, Dux L, Gecse A, Mezei Z.

Acta Biol Acad Sci Hung. 1981;32(3-4):291-300.

PMID:
6753428
49.

The effect of hypoxic and hypobaric exercises on the blood-brain barrier in rats.

Dux E, Dux L, Joó F, Gecse A, Ottlecz A, Mezei Z, Telegdy G, Bognár L, Remes P, Hideg J.

Physiologist. 1980 Dec;23(Suppl 6):S105-7. No abstract available.

PMID:
7243908

Supplemental Content

Support Center